A small study evaluated whether the use of 2 anti-inflammatories, namilumab and infliximab, could improve outcomes for patients with COVID-19 pneumonia.
All articles by Bryant Moeller
How reliable are the 10 most popular consumer pulse oximeters used for home monitoring?
An Iranian study assessed whether HScores predicted outcomes in severe COVID-19 and could thus be used to guide early treatment decisions.
Using a cohort of healthcare workers, researchers identified ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein.
The prospective SATICOVID19 study provides a detailed analysis of characteristics of invasively ventilated patients with COVID-19 in 63 ICUs in Argentina.
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
A large, retrospective study compared the asthma control effectiveness of once-daily fluticasone furoate/vilanterol vs twice-daily budesonide/formoterol.
In this study, the researchers explored the potential interaction between genetic risk and chronic obstructive pulmonary disease in relation to severe COVID-19.
Patients with treatment-refractory Mycobacterium avium complex (MAC) lung disease who received amikacin liposome inhalation suspension and guideline therapy had increased culture conversion compared with guideline therapy alone.
Patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19.